| CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging | | |
| Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting | | |
| A clinicopathologic study of malignancy in VCP-associated multisystem proteinopathy | Orphanet Journal of Rare Diseases | 2022 |
| Pancreatic Cancer and the Obesity Epidemic: A Narrative Review | Cureus | 2022 |
| Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation | International Journal of Radiation Oncology Biology Physics | 2022 |
| Preoperative therapy for pancreatic adenocarcinoma—precision beyond anatomy | Cancer | |
| The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With Nodal Metastases | Cancer Control | 2022 |
| The Role of Type 2 Diabetes in Pancreatic Cancer | Cureus | 2022 |
| Online information analysis on pancreatic cancer in Korea using structural topic model | Scientific Reports | 2022 |
| The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine | Microbiome | 2022 |
| Pancreatic cancer | | 2023 |
| Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review | Kreativnaâ Hirurgiâ I Onkologiâ | 2022 |
| Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis | BMC Cancer | 2022 |
| Designing optimal allocations for cancer screening using queuing network models | PLoS Computational Biology | 2022 |
| An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer | Cureus | 2022 |
| Magnetic Resonance Imaging of the Solid Parenchymal Organs | | 2015 |
| The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines. | Cancer Treatment Reviews | 2022 |
| Pathological and molecular diagnoses of early cancer with bile and pancreatic juice. | Digestive Endoscopy | 2022 |
| High-dimensional deconstruction of pancreatic ductal adenocarcinoma identifies tumor microenvironmental communities associated with survival | | |
| Response in mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX. | BMJ Case Reports | 2022 |
| Cinematic Rendering: Novel Tool for Improving Pancreatic Cancer Surgical Planning | Current Problems in Diagnostic Radiology | 2022 |
| Association of standardized radiology reporting and management of abdominal CT and MRI with diagnosis of pancreatic cancer. | Clinical Gastroenterology and Hepatology | 2022 |
| Decreasing length of stay and inpatient mortality associated with pancreatic cancer hospitalizations: A United States national survey from 2008 to 2017. | Pancreatology | 2022 |
| A Brief Report: Comparative Evaluation of Online Spanish and English Content on Pancreatic Cancer Treatment. | Journal of Cancer Education | 2022 |
| Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification? | Surgical Oncology | 2022 |
| Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma? | Annals of Surgical Oncology | 2022 |
| Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. | Frontiers in Oncology | 2022 |
| Hepatopancreaticobiliary Cancer in Older Adults with Frailty | | 2022 |
| The impact of radiomics in diagnosis and staging of pancreatic cancer. | Therapeutic Advances in Gastrointestinal Endoscopy | 2022 |
| Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer. | Future Oncology | 2022 |
| Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis. | BMC Medical Imaging | 2022 |
| Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysis. | Cancer Treatment Reviews | 2022 |
| NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. | Clinical and Translational Radiation Oncology | 2022 |
| Landmark Series: Importance of Pancreatic Resection Margins. | Annals of Surgical Oncology | 2022 |
| Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma | Frontiers in Medicine | 2021 |
| The patient's perspective: a qualitative study of individual experience with decision-making, treatment, and recovery for resectable pancreatic cancer | Supportive Care in Cancer | 2021 |
| Estimating the Financial Impact of Gene Therapy* | | |
| Cystic Lesions of the Pancreas | | 2021 |
| A New Era in the Adjuvant Treatment of Pancreatic Adenocarcinoma | Journal of Cancer Therapy | 2019 |
| PIK3CA in KrasG12D/Trp53R172H Tumor Cells Promotes Immune Evasion by Limiting Infiltration of T Cells in a Model of Pancreatic Cancer | | |
| Resectable and Borderline Resectable Pancreatic Cancer | | 2019 |
| Treatment Sequencing for Resectable Disease | | 2019 |
| Bile Duct Brush Cytology | Essentials in Cytopathology Series | 2019 |
| Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed | | 2018 |
| Citrullination in Inflammatory-Driven Carcinogenesis of the Colon | | 2017 |
| Diabetes and the Exocrine Pancreas | | 2017 |
| Chemotherapy in the Management of Pancreatic Cancer | | 2017 |
| Pancreatic Cancer: Background and Clinical Evidence | | 2017 |
| Pathologic Features of Primary Pancreatic Malignancies | Cancer Treatment and Research | 2016 |
| Management of Pancreatic Cancer in the Elderly | Difficult Decisions in Surgery: an Evidence-based Approach | 2016 |
| Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed Tomography | Gut and Liver | 2021 |
| Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018 | JAMA - Journal of the American Medical Association | 2021 |
| Current role of palliative interventions in advanced pancreatic cancer | World Journal of Gastrointestinal Surgery | 2018 |
| Less common etiologies of exocrine pancreatic insufficiency | World Journal of Gastroenterology | 2017 |
| Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions | World Journal of Gastroenterology | 2017 |
| Molecular detection of pancreatic neoplasia: Current status and future promise | World Journal of Gastroenterology | 2015 |
| Perspectives in the treatment of pancreatic adenocarcinoma | World Journal of Gastroenterology | 2015 |
| Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: a Surveillance, Epidemiology, and End Results (SEER) cohort study | Minerva Gastroenterologica E Dietologica | 2019 |
| Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint | Oncotarget | 2016 |
| Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial | Oncotarget | 2015 |
| Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy | PLoS ONE | 2013 |
| A novel HMM-based method for detecting enriched transcription factor binding sites reveals RUNX3 as a potential target in pancreatic cancer biology | PLoS ONE | 2010 |
| Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy | Journal of Clinical Investigation | 2020 |
| Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer | Journal of Clinical Investigation | 2019 |
| Generation of tumorigenic porcine pancreatic ductal epithelial cells: toward a large animal model of pancreatic cancer | | |
| KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion | Scientific Reports | 2020 |
| Vaccine Therapy in Pancreatic Cancer | | 2018 |
| Epidemiology of Pancreatic Cancer | | 2021 |
| Treatment Paradigms for Older Adults with Pancreatic Cancer: a Nuanced Approach | Current Treatment Options in Oncology | 2021 |
| Actual Survival in Patients with Resected Pancreatic Cancer: How Do Real-World Data Compare with Clinical Trial Evidence? | Annals of Surgical Oncology | 2021 |
| A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma | Investigational New Drugs | 2021 |
| The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance | Cancer and Metastasis Reviews | 2021 |
| Pancreatic cancer: A review of epidemiology, trend, and risk factors | World Journal of Gastroenterology | 2021 |
| The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysis | Cancer Reports | 2021 |
| Porcine pancreatic ductal epithelial cells transformed with KRAS and SV40T are tumorigenic | Scientific Reports | 2021 |
| Real-time computer-aided diagnosis of focal pancreatic masses from endoscopic ultrasound imaging based on a hybrid convolutional and long short-term memory neural network model | PLoS ONE | 2021 |
| Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis | Gut and Liver | 2021 |
| Sites of Distant Metastases and Cancer-Specific Survival in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma: A Study of 1,178 Patients | Frontiers in Oncology | 2021 |
| The Landmark Series: Preoperative Therapy for Pancreatic Cancer | Annals of Surgical Oncology | 2021 |
| Practical significance of pancreatectomy with lymphadenectomy around the superior mesenteric artery for pancreatic cancer: comparison of prognosis after adjusting for major prognostic factors | Langenbeck's Archives of Surgery | 2021 |
| Negative prognostic outcomes of percutaneous transhepatic biliary drainage in distal cholangiocarcinoma: a retrospective analysis using propensity score matching | International Journal of Clinical Oncology | 2021 |
| Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma | Annals of Surgical Oncology | 2021 |
| Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival | Journal of Surgical Oncology | 2021 |
| Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer | Molecular Therapy - Oncolytics | 2021 |
| Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis | Clinical and Translational Radiation Oncology | 2021 |
| More than acinar identity? A novel cystic phenotype suggests broader roles for NR5A2 in pancreatic cancer | Journal of Pathology | 2021 |
| Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology | Annals of Surgical Oncology | 2021 |
| Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database | Surgery Open Science | 2021 |
| Effect of gastrointestinal gas on the temperature distribution in pancreatic cancer hyperthermia treatment planning | International Journal of Hyperthermia | 2021 |
| Molecular targets in GI malignancies - A pathologist's perspective | Indian Journal of Pathology and Microbiology | 2021 |
| Patient-Reported Outcomes and Quality of Life in Pancreatic Cancer | | 2021 |
| Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinoma | Future Oncology | 2021 |
| Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma | European Radiology | 2021 |
| Contemporary Management of Pancreatic Cancer from an Internist Perspective | American Journal of Medicine | 2021 |
| Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma | Abdominal Radiology | 2021 |
| Endoscopic Ultrasound-Guided Treatment of Pancreatic Cancer | Current Gastroenterology Reports | 2020 |
| Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model | Cytotherapy | 2020 |
| Selective Induction of Cellular Toxicity and Anti-tumor Efficacy by N-Methylpiperazinyl Diarylidenylpiperidone and its Pro-nitroxide Conjugate through ROS-mediated Mitochondrial Dysfunction and G2/M Cell-cycle Arrest in Human Pancreatic Cancer | Cell Biochemistry and Biophysics | 2020 |
| Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma | Current Treatment Options in Oncology | 2020 |
| Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis | Cancer Medicine | 2020 |
